
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Marcel van den Brink discloses the following relationships and financial interests:
-
CRYOSTEM
Provision of Services (uncompensated) -
DKMS
Fiduciary Role/Position; Provision of Services -
Duke-NUS Medical School
Provision of Services -
European Federation for Immunogenetics (EFI)
Provision of Services (uncompensated) -
European Society for Blood and Marrow Transplantation (EBMT)
Provision of Services (uncompensated) -
Falk Foundation e.V.
Provision of Services (uncompensated) -
Fred Hutchinson Cancer Research Center
Provision of Services (uncompensated) -
French National Research Agency
Provision of Services (uncompensated) -
Juno Therapeutics
Intellectual Property Rights -
King Faisal Specialist Hospital & Research Centre
Provision of Services
-
Lille University Hospital (Chu De Lille)
Provision of Services (uncompensated) -
Magenta
Provision of Services (uncompensated) -
Ospedale Pediatrico Bambino Gesù
Provision of Services (uncompensated) -
Parker Institute for Cancer Immunotherapy
Provision of Services (uncompensated) -
Seres Therapeutics
Intellectual Property Rights; Ownership / Equity Interests; Provision of Services -
Technical University of Denmark
Provision of Services -
The Korean Society of Blood and Marrow Transplantation (KSBMT)
Provision of Services (uncompensated) -
The Meredith A. Cowden Foundation
Provision of Services -
University of Copenhagen
Provision of Services (uncompensated) -
Xinqiao Hospital
Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.
View all disclosures